Skip to content

Clinical Efficacy of Electroacupuncture at Different Intensities to Manage Chronic Low Back Pain: A Pilot Randomized Clinical Trial

Clinical Efficacy of Electroacupuncture at Different Intensities to Manage Chronic Low Back Pain: A Pilot Randomized Clinical Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20250516004
Enrollment
102
Registered
2025-05-16
Start date
2024-04-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients aged 18 to 65 with non-specific chronic low back pain electroacupuncture, acupuncture, low back pain, randomized controlled trial

Interventions

The Park sham device was utilized in all groups. In the sham EA group, the needles did not pierce the skin. Patients were positioned prone, and disposable stainless steel needles were employed. The se
Sham Comparator Other,Experimental Other,Active Comparator Other
Sham EA group,high-intensity EA group,low-intensity EA group

Sponsors

Tianjin Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged from 18 to 65 years old; 2. Patients with non-specific chronic low back pain were diagnosed according to the National Institutes of Health Task Force on Research Standards for Chronic Low Back Pain; 3. Visual Analog Scale (VAS) pain score > 4 in the past month (lumbar only, no significant leg pain).

Exclusion criteria

Exclusion criteria: 1. Radicular pain caused by disc compression or spinal stenosis; 2. History of lumbar surgery; 3. Received acupuncture or other pain treatment within the past month; 4. Patients on long-term opioids or corticosteroids to avoid confounding effects.

Design outcomes

Primary

MeasureTime frame
Roland Morris Disability Questionnaire Assessments were conducted every two weeks during the treatment phase and every four weeks during the follow-up period. Scale assessment

Secondary

MeasureTime frame
Visual Analogue Scale Evaluations were conducted at week 0, week 4, week 6, week 10, and week 18. Scale assessment,Pain Anxiety Symptoms Scale Evaluations were conducted at week 0, week 6, week 10, and week 18. Scale assessment,Adverse events Throughout the study period. Observation records and self-reports.

Countries

China

Contacts

Public ContactYandong Gu

Tianjin Hospital

13672063064@163.com13672063064

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026